Abstract

Introduction: MS is one of the most common inflammatory diseases of the central nervous system, with the destruction of nerves. One of the symptoms of MS disorder is dystonia, fatigue, spasticity, disturbances, lack of sensation in the organs, cognitive impairment, weakness, tremor, pain, bladder and bowel dysfunction. Method: The search was carried out in the Pubmed/Medline database. 63 The study was designed to investigate patients with MS and therapeutic samples that were materially similar to the current research, and are included in this article. Findings: Therapeutic injection methods in MS have responded, but patients are still in trouble. Studies have shown that the use of stem cells for treating patients with MS has been fruitful and can be used to treat MS. Discussion: As it has been said, the most important treatment challenges in this way is to reduce treatment, and moreover, that anti-MS drugs in advanced forms are limited. Hence, the production of new, improved medicines for the complete treatment of MS is essential. Stem cells play a veryw important role in the repair process, and the complications of these cells are low in patients and provide an acceptable response. Reliably, the focus on new immunology methods with more biological properties has a greater impact on the treatment category. They will have patients.

Highlights

  • INTRODUCTIONMS is a common inflammatory autoimmune disease of the central nervous system along with demyelination (destruction of the nerve cell membrane) of the nerves [1]

  • MS is one of the most common inflammatory diseases of the central nervous system, with the destruction of nerves

  • Stem cells play a veryw important role in the repair process, and the complications of these cells are low in patients and provide an acceptable response

Read more

Summary

INTRODUCTION

MS is a common inflammatory autoimmune disease of the central nervous system along with demyelination (destruction of the nerve cell membrane) of the nerves [1]. The third is primary progressive type, which consists of about 8-10% of cases in which neurons are continuously degraded and their patients become worse and no improvement occurs during attacks. The fourth is progressive relapsing form and From the beginning, they have progressive lesions, but they develop acute attacks that appear and disappear after a while [11,12,13], but in all patients with MS, skeletal, neurological, and equilibrium disorders [16]. One of the most important pathophysiologic mechanisms for the activation of T lymphocytes is the help of T lymphocytes that enter the brain through breaks in the blood-brain barrier These cells recognize and attack the myelin of the nerve fibers as a foreign agent. Articles containing duplicate content after deletion were reviewed, and out of a total of 936 articles, 51 articles that were relevant to the subject coverage and content structure were used in this review article

IMMUNOPATHOLOGY OF MS
MS AND STEM CELL
MESENCHIAL STEM CELLS AND MS THERAPIES
Findings
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.